These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3784698)

  • 1. Model-free evaluation and mean-time concept in pharmacokinetics.
    Brockmeier D
    Methods Find Exp Clin Pharmacol; 1986 Oct; 8(10):593-602. PubMed ID: 3784698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Criticism of pharmacokinetic clearance concepts.
    Keller F; Schoole J
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prediction of enantiomeric differences in the pharmacokinetic parameters of drugs by using a physiological perfusion model].
    Piotrovskiĭ VK; Shvachko EV; Trnovec T
    Eksp Klin Farmakol; 1994; 57(5):37-40. PubMed ID: 7696904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics: statistical moment calculations.
    Gouyette A
    Arzneimittelforschung; 1983; 33(1):173-6. PubMed ID: 6681972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimation of pharmacokinetic constants in irregular repeated drug administration (author's transl)].
    Ringwelski L; Krause D
    Arzneimittelforschung; 1978; 28(10):1766-70. PubMed ID: 582681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
    Kortejärvi H; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations].
    Pellegrin P; Lesne M
    J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic methods for the evaluation of intestinal absorption].
    Kübler W
    Z Kinderheilkd; 1970; 108(3):187-96. PubMed ID: 5475029
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability.
    Cai H; Stoner C; Reddy A; Freiwald S; Smith D; Winters R; Stankovic C; Surendran N
    Int J Pharm; 2006 Feb; 308(1-2):133-9. PubMed ID: 16352407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipophilicity and biological acitivity. Drug transport and drug distribution in model systems and in biological systems.
    Kubinyi H
    Arzneimittelforschung; 1979; 29(8):1067-80. PubMed ID: 40579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic characteristics for extent of absorption and clearance in drug/drug interaction studies.
    Schall R; Hundt HK; Luus HG
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):633-7. PubMed ID: 7881699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple electronic circuit for simulation of pharmacokinetic processes.
    Danek A; Poczatek J
    Arzneimittelforschung; 1976; 26(3):321-4. PubMed ID: 989320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical comparison between volume of distribution (V) and volume of distribution at steady-state (Vss) utilizing model-independent approach.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 Mar; 25(2):99-101. PubMed ID: 14872558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic parameters: which are necessary to define a drug substance?
    Benet LZ
    Eur J Respir Dis Suppl; 1984; 134():45-61. PubMed ID: 6586486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
    Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mean residence time in the body. A new pharmacokinetic parameter?].
    Taburet AM; Steimer JL; Doucet D; Singlas E
    Therapie; 1986; 41(1):1-10. PubMed ID: 3704987
    [No Abstract]   [Full Text] [Related]  

  • 18. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
    Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
    Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of compartment models in the pharmacokinetics].
    Weiss M; Förster W
    Z Gesamte Inn Med; 1976 Sep; 31(17):673-9. PubMed ID: 997662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics in nonlinear and partially compartmentalized systems.
    Radziuk J
    Fed Proc; 1980 May; 39(7):2450-5. PubMed ID: 7371876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.